Avalo Therapeutics (AVTX) Return on Sales Growth (3y) (2019 - 2025)
Avalo Therapeutics (AVTX) Return on Sales Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 1.00 |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | 0.00 |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | - |
| 10 | Avalo Therapeutics | 387.36 Mn | 330.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -226.00 |
| Dec 31, 2024 | -184.00 |
| Sep 30, 2024 | 92.00 |
| Jun 30, 2024 | -45.00 |
| Mar 31, 2024 | -98.00 |
| Dec 31, 2023 | -15.00 |
| Sep 30, 2023 | -22.00 |
| Jun 30, 2023 | -12.00 |
| Mar 31, 2023 | -21.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 3.00 |
| Mar 31, 2022 | 1.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 6.00 |
| Jun 30, 2021 | 1.00 |
| Mar 31, 2021 | 1.00 |
| Dec 31, 2020 | 2.00 |
| Sep 30, 2020 | -1.00 |
| Jun 30, 2020 | 11.00 |
| Mar 31, 2020 | 5.00 |